Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status

The CD44+CD24− group is considered a favorable prognostic subgroup in breast cancer. CD24 expression was a poor prognosis marker in hormone receptor positive breast cancer, and CD44 expression was a good prognostic marker in the receptor negative group.